nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—HTR2B—Sorafenib—thyroid cancer	0.138	0.258	CbGbCtD
Risperidone—HTR2C—Sorafenib—thyroid cancer	0.0896	0.168	CbGbCtD
Risperidone—CYP3A7—Sorafenib—thyroid cancer	0.0584	0.11	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0584	0.11	CbGbCtD
Risperidone—CYP3A5—Sorafenib—thyroid cancer	0.0438	0.0822	CbGbCtD
Risperidone—ABCB1—Sorafenib—thyroid cancer	0.0285	0.0535	CbGbCtD
Risperidone—CYP3A4—Vandetanib—thyroid cancer	0.0284	0.0532	CbGbCtD
Risperidone—CYP2D6—Sorafenib—thyroid cancer	0.0269	0.0504	CbGbCtD
Risperidone—ABCB1—Doxorubicin—thyroid cancer	0.0173	0.0325	CbGbCtD
Risperidone—CYP3A4—Sorafenib—thyroid cancer	0.0171	0.0321	CbGbCtD
Risperidone—CYP2D6—Doxorubicin—thyroid cancer	0.0163	0.0306	CbGbCtD
Risperidone—CYP3A4—Doxorubicin—thyroid cancer	0.0104	0.0195	CbGbCtD
Risperidone—H1F0—neck—thyroid cancer	0.00144	0.0778	CbGeAlD
Risperidone—H1F0—saliva-secreting gland—thyroid cancer	0.00112	0.0607	CbGeAlD
Risperidone—HTR7—neck—thyroid cancer	0.00089	0.048	CbGeAlD
Risperidone—H1F0—trachea—thyroid cancer	0.000867	0.0468	CbGeAlD
Risperidone—DRD3—head—thyroid cancer	0.00084	0.0453	CbGeAlD
Risperidone—H1F0—thyroid gland—thyroid cancer	0.000686	0.037	CbGeAlD
Risperidone—ADRA1B—head—thyroid cancer	0.000645	0.0348	CbGeAlD
Risperidone—H1F0—head—thyroid cancer	0.000609	0.0328	CbGeAlD
Risperidone—DRD1—head—thyroid cancer	0.000601	0.0324	CbGeAlD
Risperidone—HTR2A—neck—thyroid cancer	0.000555	0.0299	CbGeAlD
Risperidone—HTR7—trachea—thyroid cancer	0.000535	0.0289	CbGeAlD
Risperidone—HTR2B—thyroid gland—thyroid cancer	0.000495	0.0267	CbGeAlD
Risperidone—ADRA2C—trachea—thyroid cancer	0.000492	0.0265	CbGeAlD
Risperidone—HTR1B—head—thyroid cancer	0.000487	0.0263	CbGeAlD
Risperidone—HTR1D—head—thyroid cancer	0.000472	0.0254	CbGeAlD
Risperidone—HTR2C—head—thyroid cancer	0.000467	0.0252	CbGeAlD
Risperidone—HTR2B—head—thyroid cancer	0.000439	0.0237	CbGeAlD
Risperidone—H1F0—lymph node—thyroid cancer	0.000426	0.023	CbGeAlD
Risperidone—HRH1—trachea—thyroid cancer	0.0004	0.0216	CbGeAlD
Risperidone—HTR1A—head—thyroid cancer	0.000393	0.0212	CbGeAlD
Risperidone—ADRA2A—trachea—thyroid cancer	0.000393	0.0212	CbGeAlD
Risperidone—HTR7—head—thyroid cancer	0.000376	0.0203	CbGeAlD
Risperidone—ADRA1A—head—thyroid cancer	0.000362	0.0196	CbGeAlD
Risperidone—DRD2—head—thyroid cancer	0.000355	0.0192	CbGeAlD
Risperidone—KCNH2—head—thyroid cancer	0.00035	0.0189	CbGeAlD
Risperidone—ADRA2C—head—thyroid cancer	0.000345	0.0186	CbGeAlD
Risperidone—HTR2A—trachea—thyroid cancer	0.000334	0.018	CbGeAlD
Risperidone—ADRA2A—thyroid gland—thyroid cancer	0.000311	0.0168	CbGeAlD
Risperidone—HTR2B—lymph node—thyroid cancer	0.000307	0.0166	CbGeAlD
Risperidone—HRH1—head—thyroid cancer	0.00028	0.0151	CbGeAlD
Risperidone—ADRA2A—head—thyroid cancer	0.000276	0.0149	CbGeAlD
Risperidone—KCNH2—lymph node—thyroid cancer	0.000245	0.0132	CbGeAlD
Risperidone—ADRA2C—lymph node—thyroid cancer	0.000242	0.013	CbGeAlD
Risperidone—HTR2A—head—thyroid cancer	0.000234	0.0126	CbGeAlD
Risperidone—ABCB1—trachea—thyroid cancer	0.000219	0.0118	CbGeAlD
Risperidone—CYP2D6—head—thyroid cancer	0.000213	0.0115	CbGeAlD
Risperidone—HRH1—lymph node—thyroid cancer	0.000196	0.0106	CbGeAlD
Risperidone—Hypokalaemia—Doxorubicin—thyroid cancer	0.000196	0.00051	CcSEcCtD
Risperidone—Angina pectoris—Epirubicin—thyroid cancer	0.000196	0.00051	CcSEcCtD
Risperidone—Rash—Sorafenib—thyroid cancer	0.000196	0.000508	CcSEcCtD
Risperidone—Dermatitis—Sorafenib—thyroid cancer	0.000195	0.000507	CcSEcCtD
Risperidone—Breast disorder—Doxorubicin—thyroid cancer	0.000195	0.000506	CcSEcCtD
Risperidone—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000194	0.000504	CcSEcCtD
Risperidone—Headache—Sorafenib—thyroid cancer	0.000194	0.000504	CcSEcCtD
Risperidone—Bronchitis—Epirubicin—thyroid cancer	0.000194	0.000503	CcSEcCtD
Risperidone—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000193	0.000501	CcSEcCtD
Risperidone—ADRA2A—lymph node—thyroid cancer	0.000193	0.0104	CbGeAlD
Risperidone—Gastritis—Doxorubicin—thyroid cancer	0.000191	0.000496	CcSEcCtD
Risperidone—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00019	0.000494	CcSEcCtD
Risperidone—Muscular weakness—Doxorubicin—thyroid cancer	0.00019	0.000494	CcSEcCtD
Risperidone—Dysuria—Epirubicin—thyroid cancer	0.000188	0.000489	CcSEcCtD
Risperidone—Neutropenia—Epirubicin—thyroid cancer	0.000188	0.000489	CcSEcCtD
Risperidone—Abdominal distension—Doxorubicin—thyroid cancer	0.000188	0.000487	CcSEcCtD
Risperidone—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000187	0.000486	CcSEcCtD
Risperidone—Influenza—Doxorubicin—thyroid cancer	0.000186	0.000484	CcSEcCtD
Risperidone—Asthma—Doxorubicin—thyroid cancer	0.000186	0.000484	CcSEcCtD
Risperidone—Dysphagia—Doxorubicin—thyroid cancer	0.000186	0.000484	CcSEcCtD
Risperidone—Pollakiuria—Epirubicin—thyroid cancer	0.000186	0.000483	CcSEcCtD
Risperidone—Nausea—Sorafenib—thyroid cancer	0.000184	0.000478	CcSEcCtD
Risperidone—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000184	0.000478	CcSEcCtD
Risperidone—Weight increased—Epirubicin—thyroid cancer	0.000183	0.000476	CcSEcCtD
Risperidone—Pancreatitis—Doxorubicin—thyroid cancer	0.000183	0.000475	CcSEcCtD
Risperidone—Weight decreased—Epirubicin—thyroid cancer	0.000182	0.000473	CcSEcCtD
Risperidone—Hyperglycaemia—Epirubicin—thyroid cancer	0.000182	0.000472	CcSEcCtD
Risperidone—Angina pectoris—Doxorubicin—thyroid cancer	0.000182	0.000472	CcSEcCtD
Risperidone—Pneumonia—Epirubicin—thyroid cancer	0.000181	0.000469	CcSEcCtD
Risperidone—Infestation NOS—Epirubicin—thyroid cancer	0.00018	0.000467	CcSEcCtD
Risperidone—Drowsiness—Epirubicin—thyroid cancer	0.00018	0.000467	CcSEcCtD
Risperidone—Infestation—Epirubicin—thyroid cancer	0.00018	0.000467	CcSEcCtD
Risperidone—Bronchitis—Doxorubicin—thyroid cancer	0.000179	0.000466	CcSEcCtD
Risperidone—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000178	0.000463	CcSEcCtD
Risperidone—Renal failure—Epirubicin—thyroid cancer	0.000177	0.000459	CcSEcCtD
Risperidone—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000176	0.000457	CcSEcCtD
Risperidone—Stomatitis—Epirubicin—thyroid cancer	0.000175	0.000455	CcSEcCtD
Risperidone—Jaundice—Epirubicin—thyroid cancer	0.000175	0.000455	CcSEcCtD
Risperidone—Urinary tract infection—Epirubicin—thyroid cancer	0.000175	0.000453	CcSEcCtD
Risperidone—Conjunctivitis—Epirubicin—thyroid cancer	0.000175	0.000453	CcSEcCtD
Risperidone—Neutropenia—Doxorubicin—thyroid cancer	0.000174	0.000453	CcSEcCtD
Risperidone—Dysuria—Doxorubicin—thyroid cancer	0.000174	0.000453	CcSEcCtD
Risperidone—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000173	0.00045	CcSEcCtD
Risperidone—ABCB1—thyroid gland—thyroid cancer	0.000173	0.00934	CbGeAlD
Risperidone—Sweating—Epirubicin—thyroid cancer	0.000172	0.000447	CcSEcCtD
Risperidone—Pollakiuria—Doxorubicin—thyroid cancer	0.000172	0.000447	CcSEcCtD
Risperidone—Haematuria—Epirubicin—thyroid cancer	0.000171	0.000445	CcSEcCtD
Risperidone—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00017	0.000442	CcSEcCtD
Risperidone—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00017	0.000441	CcSEcCtD
Risperidone—Weight increased—Doxorubicin—thyroid cancer	0.00017	0.000441	CcSEcCtD
Risperidone—Epistaxis—Epirubicin—thyroid cancer	0.000169	0.00044	CcSEcCtD
Risperidone—Weight decreased—Doxorubicin—thyroid cancer	0.000169	0.000438	CcSEcCtD
Risperidone—Sinusitis—Epirubicin—thyroid cancer	0.000169	0.000438	CcSEcCtD
Risperidone—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000168	0.000437	CcSEcCtD
Risperidone—Agranulocytosis—Epirubicin—thyroid cancer	0.000168	0.000435	CcSEcCtD
Risperidone—Pneumonia—Doxorubicin—thyroid cancer	0.000167	0.000434	CcSEcCtD
Risperidone—Infestation NOS—Doxorubicin—thyroid cancer	0.000166	0.000432	CcSEcCtD
Risperidone—Infestation—Doxorubicin—thyroid cancer	0.000166	0.000432	CcSEcCtD
Risperidone—Drowsiness—Doxorubicin—thyroid cancer	0.000166	0.000432	CcSEcCtD
Risperidone—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000165	0.000428	CcSEcCtD
Risperidone—Bradycardia—Epirubicin—thyroid cancer	0.000164	0.000426	CcSEcCtD
Risperidone—Renal failure—Doxorubicin—thyroid cancer	0.000163	0.000424	CcSEcCtD
Risperidone—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000163	0.000423	CcSEcCtD
Risperidone—Haemoglobin—Epirubicin—thyroid cancer	0.000162	0.000421	CcSEcCtD
Risperidone—Jaundice—Doxorubicin—thyroid cancer	0.000162	0.000421	CcSEcCtD
Risperidone—Stomatitis—Doxorubicin—thyroid cancer	0.000162	0.000421	CcSEcCtD
Risperidone—Rhinitis—Epirubicin—thyroid cancer	0.000162	0.00042	CcSEcCtD
Risperidone—Urinary tract infection—Doxorubicin—thyroid cancer	0.000162	0.00042	CcSEcCtD
Risperidone—Conjunctivitis—Doxorubicin—thyroid cancer	0.000162	0.00042	CcSEcCtD
Risperidone—Hepatitis—Epirubicin—thyroid cancer	0.000161	0.000419	CcSEcCtD
Risperidone—Haemorrhage—Epirubicin—thyroid cancer	0.000161	0.000419	CcSEcCtD
Risperidone—Hypoaesthesia—Epirubicin—thyroid cancer	0.000161	0.000417	CcSEcCtD
Risperidone—Pharyngitis—Epirubicin—thyroid cancer	0.00016	0.000416	CcSEcCtD
Risperidone—Sweating—Doxorubicin—thyroid cancer	0.000159	0.000414	CcSEcCtD
Risperidone—Urinary tract disorder—Epirubicin—thyroid cancer	0.000159	0.000414	CcSEcCtD
Risperidone—Oedema peripheral—Epirubicin—thyroid cancer	0.000159	0.000413	CcSEcCtD
Risperidone—Haematuria—Doxorubicin—thyroid cancer	0.000159	0.000412	CcSEcCtD
Risperidone—Connective tissue disorder—Epirubicin—thyroid cancer	0.000159	0.000412	CcSEcCtD
Risperidone—Urethral disorder—Epirubicin—thyroid cancer	0.000158	0.000411	CcSEcCtD
Risperidone—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000157	0.000408	CcSEcCtD
Risperidone—Epistaxis—Doxorubicin—thyroid cancer	0.000157	0.000407	CcSEcCtD
Risperidone—Sinusitis—Doxorubicin—thyroid cancer	0.000156	0.000405	CcSEcCtD
Risperidone—Visual impairment—Epirubicin—thyroid cancer	0.000155	0.000404	CcSEcCtD
Risperidone—Agranulocytosis—Doxorubicin—thyroid cancer	0.000155	0.000403	CcSEcCtD
Risperidone—ABCB1—head—thyroid cancer	0.000154	0.00828	CbGeAlD
Risperidone—Erythema multiforme—Epirubicin—thyroid cancer	0.000153	0.000396	CcSEcCtD
Risperidone—Bradycardia—Doxorubicin—thyroid cancer	0.000152	0.000395	CcSEcCtD
Risperidone—Eye disorder—Epirubicin—thyroid cancer	0.000151	0.000391	CcSEcCtD
Risperidone—Tinnitus—Epirubicin—thyroid cancer	0.00015	0.00039	CcSEcCtD
Risperidone—Haemoglobin—Doxorubicin—thyroid cancer	0.00015	0.000389	CcSEcCtD
Risperidone—Flushing—Epirubicin—thyroid cancer	0.00015	0.000389	CcSEcCtD
Risperidone—Cardiac disorder—Epirubicin—thyroid cancer	0.00015	0.000389	CcSEcCtD
Risperidone—Rhinitis—Doxorubicin—thyroid cancer	0.00015	0.000389	CcSEcCtD
Risperidone—Hepatitis—Doxorubicin—thyroid cancer	0.000149	0.000388	CcSEcCtD
Risperidone—Haemorrhage—Doxorubicin—thyroid cancer	0.000149	0.000388	CcSEcCtD
Risperidone—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000149	0.000386	CcSEcCtD
Risperidone—Pharyngitis—Doxorubicin—thyroid cancer	0.000148	0.000385	CcSEcCtD
Risperidone—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000147	0.000383	CcSEcCtD
Risperidone—Oedema peripheral—Doxorubicin—thyroid cancer	0.000147	0.000382	CcSEcCtD
Risperidone—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000147	0.000381	CcSEcCtD
Risperidone—Angiopathy—Epirubicin—thyroid cancer	0.000146	0.00038	CcSEcCtD
Risperidone—Urethral disorder—Doxorubicin—thyroid cancer	0.000146	0.00038	CcSEcCtD
Risperidone—Immune system disorder—Epirubicin—thyroid cancer	0.000146	0.000378	CcSEcCtD
Risperidone—Mediastinal disorder—Epirubicin—thyroid cancer	0.000145	0.000377	CcSEcCtD
Risperidone—Chills—Epirubicin—thyroid cancer	0.000145	0.000376	CcSEcCtD
Risperidone—Arrhythmia—Epirubicin—thyroid cancer	0.000144	0.000374	CcSEcCtD
Risperidone—Visual impairment—Doxorubicin—thyroid cancer	0.000144	0.000373	CcSEcCtD
Risperidone—Alopecia—Epirubicin—thyroid cancer	0.000143	0.00037	CcSEcCtD
Risperidone—Mental disorder—Epirubicin—thyroid cancer	0.000141	0.000367	CcSEcCtD
Risperidone—Erythema multiforme—Doxorubicin—thyroid cancer	0.000141	0.000366	CcSEcCtD
Risperidone—Malnutrition—Epirubicin—thyroid cancer	0.00014	0.000365	CcSEcCtD
Risperidone—Erythema—Epirubicin—thyroid cancer	0.00014	0.000365	CcSEcCtD
Risperidone—Eye disorder—Doxorubicin—thyroid cancer	0.000139	0.000362	CcSEcCtD
Risperidone—Tinnitus—Doxorubicin—thyroid cancer	0.000139	0.000361	CcSEcCtD
Risperidone—Flushing—Doxorubicin—thyroid cancer	0.000139	0.00036	CcSEcCtD
Risperidone—Cardiac disorder—Doxorubicin—thyroid cancer	0.000139	0.00036	CcSEcCtD
Risperidone—Flatulence—Epirubicin—thyroid cancer	0.000138	0.000359	CcSEcCtD
Risperidone—Tension—Epirubicin—thyroid cancer	0.000138	0.000358	CcSEcCtD
Risperidone—Dysgeusia—Epirubicin—thyroid cancer	0.000138	0.000357	CcSEcCtD
Risperidone—Nervousness—Epirubicin—thyroid cancer	0.000136	0.000354	CcSEcCtD
Risperidone—Back pain—Epirubicin—thyroid cancer	0.000136	0.000353	CcSEcCtD
Risperidone—Angiopathy—Doxorubicin—thyroid cancer	0.000135	0.000352	CcSEcCtD
Risperidone—Muscle spasms—Epirubicin—thyroid cancer	0.000135	0.000351	CcSEcCtD
Risperidone—Immune system disorder—Doxorubicin—thyroid cancer	0.000135	0.00035	CcSEcCtD
Risperidone—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000135	0.000349	CcSEcCtD
Risperidone—Chills—Doxorubicin—thyroid cancer	0.000134	0.000348	CcSEcCtD
Risperidone—Arrhythmia—Doxorubicin—thyroid cancer	0.000133	0.000346	CcSEcCtD
Risperidone—Vision blurred—Epirubicin—thyroid cancer	0.000132	0.000344	CcSEcCtD
Risperidone—Alopecia—Doxorubicin—thyroid cancer	0.000132	0.000342	CcSEcCtD
Risperidone—Mental disorder—Doxorubicin—thyroid cancer	0.000131	0.00034	CcSEcCtD
Risperidone—Ill-defined disorder—Epirubicin—thyroid cancer	0.00013	0.000338	CcSEcCtD
Risperidone—Malnutrition—Doxorubicin—thyroid cancer	0.00013	0.000337	CcSEcCtD
Risperidone—Erythema—Doxorubicin—thyroid cancer	0.00013	0.000337	CcSEcCtD
Risperidone—Anaemia—Epirubicin—thyroid cancer	0.00013	0.000337	CcSEcCtD
Risperidone—Agitation—Epirubicin—thyroid cancer	0.000129	0.000335	CcSEcCtD
Risperidone—Flatulence—Doxorubicin—thyroid cancer	0.000128	0.000332	CcSEcCtD
Risperidone—Tension—Doxorubicin—thyroid cancer	0.000128	0.000331	CcSEcCtD
Risperidone—Dysgeusia—Doxorubicin—thyroid cancer	0.000127	0.00033	CcSEcCtD
Risperidone—Malaise—Epirubicin—thyroid cancer	0.000127	0.000329	CcSEcCtD
Risperidone—Nervousness—Doxorubicin—thyroid cancer	0.000126	0.000328	CcSEcCtD
Risperidone—Vertigo—Epirubicin—thyroid cancer	0.000126	0.000328	CcSEcCtD
Risperidone—Syncope—Epirubicin—thyroid cancer	0.000126	0.000327	CcSEcCtD
Risperidone—Leukopenia—Epirubicin—thyroid cancer	0.000126	0.000326	CcSEcCtD
Risperidone—Back pain—Doxorubicin—thyroid cancer	0.000126	0.000326	CcSEcCtD
Risperidone—Muscle spasms—Doxorubicin—thyroid cancer	0.000125	0.000324	CcSEcCtD
Risperidone—Palpitations—Epirubicin—thyroid cancer	0.000124	0.000322	CcSEcCtD
Risperidone—Loss of consciousness—Epirubicin—thyroid cancer	0.000123	0.00032	CcSEcCtD
Risperidone—Cough—Epirubicin—thyroid cancer	0.000123	0.000318	CcSEcCtD
Risperidone—Vision blurred—Doxorubicin—thyroid cancer	0.000122	0.000318	CcSEcCtD
Risperidone—Convulsion—Epirubicin—thyroid cancer	0.000122	0.000316	CcSEcCtD
Risperidone—Hypertension—Epirubicin—thyroid cancer	0.000121	0.000315	CcSEcCtD
Risperidone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000121	0.000313	CcSEcCtD
Risperidone—Anaemia—Doxorubicin—thyroid cancer	0.00012	0.000312	CcSEcCtD
Risperidone—Chest pain—Epirubicin—thyroid cancer	0.00012	0.00031	CcSEcCtD
Risperidone—Arthralgia—Epirubicin—thyroid cancer	0.00012	0.00031	CcSEcCtD
Risperidone—Myalgia—Epirubicin—thyroid cancer	0.00012	0.00031	CcSEcCtD
Risperidone—Agitation—Doxorubicin—thyroid cancer	0.000119	0.00031	CcSEcCtD
Risperidone—Anxiety—Epirubicin—thyroid cancer	0.000119	0.000309	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000119	0.000308	CcSEcCtD
Risperidone—Discomfort—Epirubicin—thyroid cancer	0.000118	0.000307	CcSEcCtD
Risperidone—Malaise—Doxorubicin—thyroid cancer	0.000117	0.000304	CcSEcCtD
Risperidone—Dry mouth—Epirubicin—thyroid cancer	0.000117	0.000304	CcSEcCtD
Risperidone—Vertigo—Doxorubicin—thyroid cancer	0.000117	0.000303	CcSEcCtD
Risperidone—Syncope—Doxorubicin—thyroid cancer	0.000117	0.000303	CcSEcCtD
Risperidone—Leukopenia—Doxorubicin—thyroid cancer	0.000116	0.000302	CcSEcCtD
Risperidone—Confusional state—Epirubicin—thyroid cancer	0.000116	0.0003	CcSEcCtD
Risperidone—Palpitations—Doxorubicin—thyroid cancer	0.000115	0.000298	CcSEcCtD
Risperidone—Oedema—Epirubicin—thyroid cancer	0.000115	0.000298	CcSEcCtD
Risperidone—Anaphylactic shock—Epirubicin—thyroid cancer	0.000115	0.000298	CcSEcCtD
Risperidone—Loss of consciousness—Doxorubicin—thyroid cancer	0.000114	0.000297	CcSEcCtD
Risperidone—Infection—Epirubicin—thyroid cancer	0.000114	0.000296	CcSEcCtD
Risperidone—Cough—Doxorubicin—thyroid cancer	0.000113	0.000294	CcSEcCtD
Risperidone—Shock—Epirubicin—thyroid cancer	0.000113	0.000293	CcSEcCtD
Risperidone—Convulsion—Doxorubicin—thyroid cancer	0.000113	0.000292	CcSEcCtD
Risperidone—Nervous system disorder—Epirubicin—thyroid cancer	0.000112	0.000292	CcSEcCtD
Risperidone—Thrombocytopenia—Epirubicin—thyroid cancer	0.000112	0.000291	CcSEcCtD
Risperidone—Hypertension—Doxorubicin—thyroid cancer	0.000112	0.000291	CcSEcCtD
Risperidone—Tachycardia—Epirubicin—thyroid cancer	0.000112	0.00029	CcSEcCtD
Risperidone—Skin disorder—Epirubicin—thyroid cancer	0.000111	0.000289	CcSEcCtD
Risperidone—Hyperhidrosis—Epirubicin—thyroid cancer	0.000111	0.000288	CcSEcCtD
Risperidone—Chest pain—Doxorubicin—thyroid cancer	0.000111	0.000287	CcSEcCtD
Risperidone—Arthralgia—Doxorubicin—thyroid cancer	0.000111	0.000287	CcSEcCtD
Risperidone—Myalgia—Doxorubicin—thyroid cancer	0.000111	0.000287	CcSEcCtD
Risperidone—Anxiety—Doxorubicin—thyroid cancer	0.00011	0.000286	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00011	0.000285	CcSEcCtD
Risperidone—Discomfort—Doxorubicin—thyroid cancer	0.000109	0.000284	CcSEcCtD
Risperidone—Anorexia—Epirubicin—thyroid cancer	0.000109	0.000284	CcSEcCtD
Risperidone—Dry mouth—Doxorubicin—thyroid cancer	0.000108	0.000281	CcSEcCtD
Risperidone—ABCB1—lymph node—thyroid cancer	0.000107	0.0058	CbGeAlD
Risperidone—Hypotension—Epirubicin—thyroid cancer	0.000107	0.000278	CcSEcCtD
Risperidone—Confusional state—Doxorubicin—thyroid cancer	0.000107	0.000278	CcSEcCtD
Risperidone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000106	0.000275	CcSEcCtD
Risperidone—Oedema—Doxorubicin—thyroid cancer	0.000106	0.000275	CcSEcCtD
Risperidone—Infection—Doxorubicin—thyroid cancer	0.000105	0.000274	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000104	0.000271	CcSEcCtD
Risperidone—Shock—Doxorubicin—thyroid cancer	0.000104	0.000271	CcSEcCtD
Risperidone—Nervous system disorder—Doxorubicin—thyroid cancer	0.000104	0.00027	CcSEcCtD
Risperidone—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000104	0.00027	CcSEcCtD
Risperidone—Insomnia—Epirubicin—thyroid cancer	0.000104	0.000269	CcSEcCtD
Risperidone—Tachycardia—Doxorubicin—thyroid cancer	0.000103	0.000269	CcSEcCtD
Risperidone—Skin disorder—Doxorubicin—thyroid cancer	0.000103	0.000267	CcSEcCtD
Risperidone—Paraesthesia—Epirubicin—thyroid cancer	0.000103	0.000267	CcSEcCtD
Risperidone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000103	0.000266	CcSEcCtD
Risperidone—Dyspnoea—Epirubicin—thyroid cancer	0.000102	0.000265	CcSEcCtD
Risperidone—Somnolence—Epirubicin—thyroid cancer	0.000102	0.000265	CcSEcCtD
Risperidone—Anorexia—Doxorubicin—thyroid cancer	0.000101	0.000262	CcSEcCtD
Risperidone—Dyspepsia—Epirubicin—thyroid cancer	0.000101	0.000262	CcSEcCtD
Risperidone—Decreased appetite—Epirubicin—thyroid cancer	9.96e-05	0.000259	CcSEcCtD
Risperidone—Hypotension—Doxorubicin—thyroid cancer	9.91e-05	0.000257	CcSEcCtD
Risperidone—Gastrointestinal disorder—Epirubicin—thyroid cancer	9.89e-05	0.000257	CcSEcCtD
Risperidone—Fatigue—Epirubicin—thyroid cancer	9.88e-05	0.000257	CcSEcCtD
Risperidone—Constipation—Epirubicin—thyroid cancer	9.8e-05	0.000254	CcSEcCtD
Risperidone—Pain—Epirubicin—thyroid cancer	9.8e-05	0.000254	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	9.66e-05	0.000251	CcSEcCtD
Risperidone—Insomnia—Doxorubicin—thyroid cancer	9.59e-05	0.000249	CcSEcCtD
Risperidone—Paraesthesia—Doxorubicin—thyroid cancer	9.52e-05	0.000247	CcSEcCtD
Risperidone—Dyspnoea—Doxorubicin—thyroid cancer	9.45e-05	0.000245	CcSEcCtD
Risperidone—Feeling abnormal—Epirubicin—thyroid cancer	9.44e-05	0.000245	CcSEcCtD
Risperidone—Somnolence—Doxorubicin—thyroid cancer	9.43e-05	0.000245	CcSEcCtD
Risperidone—Gastrointestinal pain—Epirubicin—thyroid cancer	9.37e-05	0.000243	CcSEcCtD
Risperidone—Dyspepsia—Doxorubicin—thyroid cancer	9.33e-05	0.000242	CcSEcCtD
Risperidone—Decreased appetite—Doxorubicin—thyroid cancer	9.22e-05	0.000239	CcSEcCtD
Risperidone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	9.16e-05	0.000238	CcSEcCtD
Risperidone—Fatigue—Doxorubicin—thyroid cancer	9.14e-05	0.000237	CcSEcCtD
Risperidone—Urticaria—Epirubicin—thyroid cancer	9.1e-05	0.000236	CcSEcCtD
Risperidone—Pain—Doxorubicin—thyroid cancer	9.07e-05	0.000235	CcSEcCtD
Risperidone—Constipation—Doxorubicin—thyroid cancer	9.07e-05	0.000235	CcSEcCtD
Risperidone—Abdominal pain—Epirubicin—thyroid cancer	9.06e-05	0.000235	CcSEcCtD
Risperidone—Body temperature increased—Epirubicin—thyroid cancer	9.06e-05	0.000235	CcSEcCtD
Risperidone—Feeling abnormal—Doxorubicin—thyroid cancer	8.74e-05	0.000227	CcSEcCtD
Risperidone—Gastrointestinal pain—Doxorubicin—thyroid cancer	8.67e-05	0.000225	CcSEcCtD
Risperidone—Hypersensitivity—Epirubicin—thyroid cancer	8.44e-05	0.000219	CcSEcCtD
Risperidone—Urticaria—Doxorubicin—thyroid cancer	8.42e-05	0.000219	CcSEcCtD
Risperidone—Body temperature increased—Doxorubicin—thyroid cancer	8.38e-05	0.000218	CcSEcCtD
Risperidone—Abdominal pain—Doxorubicin—thyroid cancer	8.38e-05	0.000218	CcSEcCtD
Risperidone—Asthenia—Epirubicin—thyroid cancer	8.22e-05	0.000213	CcSEcCtD
Risperidone—Pruritus—Epirubicin—thyroid cancer	8.11e-05	0.000211	CcSEcCtD
Risperidone—Diarrhoea—Epirubicin—thyroid cancer	7.84e-05	0.000204	CcSEcCtD
Risperidone—Hypersensitivity—Doxorubicin—thyroid cancer	7.81e-05	0.000203	CcSEcCtD
Risperidone—Asthenia—Doxorubicin—thyroid cancer	7.61e-05	0.000198	CcSEcCtD
Risperidone—Dizziness—Epirubicin—thyroid cancer	7.58e-05	0.000197	CcSEcCtD
Risperidone—Pruritus—Doxorubicin—thyroid cancer	7.5e-05	0.000195	CcSEcCtD
Risperidone—Vomiting—Epirubicin—thyroid cancer	7.29e-05	0.000189	CcSEcCtD
Risperidone—Diarrhoea—Doxorubicin—thyroid cancer	7.26e-05	0.000188	CcSEcCtD
Risperidone—Rash—Epirubicin—thyroid cancer	7.23e-05	0.000188	CcSEcCtD
Risperidone—Dermatitis—Epirubicin—thyroid cancer	7.22e-05	0.000187	CcSEcCtD
Risperidone—Headache—Epirubicin—thyroid cancer	7.18e-05	0.000186	CcSEcCtD
Risperidone—Dizziness—Doxorubicin—thyroid cancer	7.01e-05	0.000182	CcSEcCtD
Risperidone—Nausea—Epirubicin—thyroid cancer	6.81e-05	0.000177	CcSEcCtD
Risperidone—Vomiting—Doxorubicin—thyroid cancer	6.74e-05	0.000175	CcSEcCtD
Risperidone—Rash—Doxorubicin—thyroid cancer	6.69e-05	0.000174	CcSEcCtD
Risperidone—Dermatitis—Doxorubicin—thyroid cancer	6.68e-05	0.000173	CcSEcCtD
Risperidone—Headache—Doxorubicin—thyroid cancer	6.64e-05	0.000172	CcSEcCtD
Risperidone—Nausea—Doxorubicin—thyroid cancer	6.3e-05	0.000164	CcSEcCtD
Risperidone—DRD3—Signaling Pathways—BRAF—thyroid cancer	1.31e-05	0.000207	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—KRAS—thyroid cancer	1.29e-05	0.000204	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—TP53—thyroid cancer	1.28e-05	0.000201	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TERT—thyroid cancer	1.27e-05	0.0002	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	1.27e-05	0.0002	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—NRAS—thyroid cancer	1.26e-05	0.000199	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TERT—thyroid cancer	1.25e-05	0.000197	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TERT—thyroid cancer	1.25e-05	0.000197	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TERT—thyroid cancer	1.22e-05	0.000193	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—HRAS—thyroid cancer	1.22e-05	0.000193	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—KRAS—thyroid cancer	1.22e-05	0.000192	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	1.22e-05	0.000192	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HIF1A—thyroid cancer	1.21e-05	0.000191	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	1.21e-05	0.000191	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—RXRA—thyroid cancer	1.21e-05	0.000191	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—KRAS—thyroid cancer	1.2e-05	0.00019	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—HRAS—thyroid cancer	1.2e-05	0.00019	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—HRAS—thyroid cancer	1.2e-05	0.000188	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—HIF1A—thyroid cancer	1.2e-05	0.000188	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HIF1A—thyroid cancer	1.19e-05	0.000188	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—BRAF—thyroid cancer	1.19e-05	0.000187	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—TPR—thyroid cancer	1.19e-05	0.000187	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—NRAS—thyroid cancer	1.18e-05	0.000186	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—HRAS—thyroid cancer	1.17e-05	0.000185	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	1.17e-05	0.000184	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—AKT1—thyroid cancer	1.17e-05	0.000184	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.17e-05	0.000184	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—AKT1—thyroid cancer	1.16e-05	0.000183	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—NRAS—thyroid cancer	1.16e-05	0.000183	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—HRAS—thyroid cancer	1.15e-05	0.000182	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—BRAF—thyroid cancer	1.15e-05	0.000181	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—RXRA—thyroid cancer	1.14e-05	0.00018	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—BRAF—thyroid cancer	1.14e-05	0.00018	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—AKT1—thyroid cancer	1.14e-05	0.000179	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TERT—thyroid cancer	1.14e-05	0.000179	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CCND1—thyroid cancer	1.13e-05	0.000178	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CCND1—thyroid cancer	1.12e-05	0.000177	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—AKT1—thyroid cancer	1.12e-05	0.000177	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—BRAF—thyroid cancer	1.11e-05	0.000175	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PPARG—thyroid cancer	1.11e-05	0.000174	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PTGS2—thyroid cancer	1.1e-05	0.000174	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—HRAS—thyroid cancer	1.1e-05	0.000173	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CCND1—thyroid cancer	1.1e-05	0.000173	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	1.09e-05	0.000172	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—PTEN—thyroid cancer	1.09e-05	0.000172	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	1.09e-05	0.000171	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	1.09e-05	0.000171	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—PTEN—thyroid cancer	1.08e-05	0.000171	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CCND1—thyroid cancer	1.08e-05	0.00017	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—AKT1—thyroid cancer	1.08e-05	0.00017	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PTGS2—thyroid cancer	1.07e-05	0.000169	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—NRAS—thyroid cancer	1.07e-05	0.000169	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—AKT1—thyroid cancer	1.07e-05	0.000169	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—AKT1—thyroid cancer	1.06e-05	0.000167	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—PTEN—thyroid cancer	1.06e-05	0.000167	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—AKT1—thyroid cancer	1.06e-05	0.000166	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	1.05e-05	0.000166	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—NRAS—thyroid cancer	1.05e-05	0.000166	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	1.05e-05	0.000165	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	1.04e-05	0.000165	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—PTEN—thyroid cancer	1.04e-05	0.000164	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—HRAS—thyroid cancer	1.04e-05	0.000163	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—AKT1—thyroid cancer	1.03e-05	0.000163	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CCND1—thyroid cancer	1.03e-05	0.000163	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	1.03e-05	0.000163	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—HRAS—thyroid cancer	1.02e-05	0.000161	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—AKT1—thyroid cancer	1.02e-05	0.00016	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—KRAS—thyroid cancer	1.02e-05	0.00016	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PPARG—thyroid cancer	1.01e-05	0.00016	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—AKT1—thyroid cancer	1.01e-05	0.000159	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—BRAF—thyroid cancer	1.01e-05	0.000159	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	9.99e-06	0.000157	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—PTEN—thyroid cancer	9.95e-06	0.000157	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—AKT1—thyroid cancer	9.95e-06	0.000157	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—BRAF—thyroid cancer	9.9e-06	0.000156	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—BRAF—thyroid cancer	9.88e-06	0.000156	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CCND1—thyroid cancer	9.72e-06	0.000153	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—NRAS—thyroid cancer	9.72e-06	0.000153	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—AKT1—thyroid cancer	9.71e-06	0.000153	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	9.69e-06	0.000153	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—NRAS—thyroid cancer	9.65e-06	0.000152	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PTEN—thyroid cancer	9.62e-06	0.000152	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CCND1—thyroid cancer	9.6e-06	0.000151	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	9.58e-06	0.000151	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—NRAS—thyroid cancer	9.45e-06	0.000149	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—PTEN—thyroid cancer	9.39e-06	0.000148	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PTEN—thyroid cancer	9.34e-06	0.000147	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—NRAS—thyroid cancer	9.3e-06	0.000147	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PTEN—thyroid cancer	9.26e-06	0.000146	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	9.24e-06	0.000146	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—KRAS—thyroid cancer	9.21e-06	0.000145	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—AKT1—thyroid cancer	9.16e-06	0.000144	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	9.06e-06	0.000143	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—KRAS—thyroid cancer	9.04e-06	0.000143	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—AKT1—thyroid cancer	9.04e-06	0.000142	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	9.01e-06	0.000142	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	8.98e-06	0.000142	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	8.92e-06	0.000141	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	8.88e-06	0.00014	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—NRAS—thyroid cancer	8.88e-06	0.00014	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	8.88e-06	0.00014	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	8.87e-06	0.00014	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PTGS2—thyroid cancer	8.7e-06	0.000137	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	8.67e-06	0.000137	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	8.66e-06	0.000137	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—HRAS—thyroid cancer	8.63e-06	0.000136	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	8.63e-06	0.000136	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	8.49e-06	0.000134	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—AKT1—thyroid cancer	8.39e-06	0.000132	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—NRAS—thyroid cancer	8.37e-06	0.000132	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—KRAS—thyroid cancer	8.36e-06	0.000132	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CCND1—thyroid cancer	8.36e-06	0.000132	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	8.36e-06	0.000132	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CCND1—thyroid cancer	8.32e-06	0.000131	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—KRAS—thyroid cancer	8.31e-06	0.000131	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—NRAS—thyroid cancer	8.26e-06	0.00013	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	8.26e-06	0.00013	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	8.25e-06	0.00013	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	8.16e-06	0.000129	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—KRAS—thyroid cancer	8.14e-06	0.000128	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CCND1—thyroid cancer	8.09e-06	0.000128	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PTEN—thyroid cancer	8.07e-06	0.000127	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PTEN—thyroid cancer	8.03e-06	0.000127	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—KRAS—thyroid cancer	8.01e-06	0.000126	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTGS2—thyroid cancer	7.97e-06	0.000126	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	7.96e-06	0.000126	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	7.87e-06	0.000124	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	7.83e-06	0.000123	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—HRAS—thyroid cancer	7.83e-06	0.000123	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PTEN—thyroid cancer	7.81e-06	0.000123	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	7.7e-06	0.000121	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—HRAS—thyroid cancer	7.69e-06	0.000121	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	7.69e-06	0.000121	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PPARG—thyroid cancer	7.65e-06	0.000121	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—KRAS—thyroid cancer	7.64e-06	0.00012	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—AKT1—thyroid cancer	7.62e-06	0.00012	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	7.61e-06	0.00012	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PTEN—thyroid cancer	7.59e-06	0.00012	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	7.54e-06	0.000119	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	7.5e-06	0.000118	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	7.49e-06	0.000118	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	7.48e-06	0.000118	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—RXRA—thyroid cancer	7.46e-06	0.000118	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	7.46e-06	0.000118	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—thyroid cancer	7.43e-06	0.000117	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—thyroid cancer	7.39e-06	0.000116	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCND1—thyroid cancer	7.34e-06	0.000116	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	7.34e-06	0.000116	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—thyroid cancer	7.23e-06	0.000114	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCND1—thyroid cancer	7.22e-06	0.000114	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCND1—thyroid cancer	7.21e-06	0.000114	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—KRAS—thyroid cancer	7.21e-06	0.000114	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PPARG—thyroid cancer	7.21e-06	0.000114	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—NRAS—thyroid cancer	7.2e-06	0.000114	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—NRAS—thyroid cancer	7.16e-06	0.000113	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—thyroid cancer	7.12e-06	0.000112	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—KRAS—thyroid cancer	7.11e-06	0.000112	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—HRAS—thyroid cancer	7.11e-06	0.000112	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PTEN—thyroid cancer	7.09e-06	0.000112	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	7.07e-06	0.000112	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—HRAS—thyroid cancer	7.06e-06	0.000111	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	7.01e-06	0.00011	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PTEN—thyroid cancer	6.97e-06	0.00011	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—NRAS—thyroid cancer	6.97e-06	0.00011	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PTEN—thyroid cancer	6.96e-06	0.00011	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTEN—thyroid cancer	6.95e-06	0.00011	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—HRAS—thyroid cancer	6.92e-06	0.000109	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—AKT1—thyroid cancer	6.91e-06	0.000109	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	6.86e-06	0.000108	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	6.83e-06	0.000108	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	6.82e-06	0.000107	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—HRAS—thyroid cancer	6.81e-06	0.000107	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	6.8e-06	0.000107	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—thyroid cancer	6.79e-06	0.000107	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—AKT1—thyroid cancer	6.79e-06	0.000107	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	6.66e-06	0.000105	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	6.57e-06	0.000104	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—HRAS—thyroid cancer	6.5e-06	0.000102	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	6.42e-06	0.000101	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—thyroid cancer	6.41e-06	0.000101	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	6.34e-06	0.0001	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NRAS—thyroid cancer	6.32e-06	9.97e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—thyroid cancer	6.32e-06	9.96e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—AKT1—thyroid cancer	6.28e-06	9.89e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—AKT1—thyroid cancer	6.24e-06	9.83e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NRAS—thyroid cancer	6.22e-06	9.81e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NRAS—thyroid cancer	6.21e-06	9.78e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—KRAS—thyroid cancer	6.2e-06	9.77e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	6.19e-06	9.76e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—KRAS—thyroid cancer	6.17e-06	9.72e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—HRAS—thyroid cancer	6.13e-06	9.66e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—AKT1—thyroid cancer	6.11e-06	9.63e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	6.09e-06	9.6e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—HRAS—thyroid cancer	6.04e-06	9.53e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTGS2—thyroid cancer	6.02e-06	9.48e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—AKT1—thyroid cancer	6.01e-06	9.47e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—KRAS—thyroid cancer	6e-06	9.45e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	5.9e-06	9.3e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—AKT1—thyroid cancer	5.74e-06	9.04e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—thyroid cancer	5.71e-06	8.99e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTGS2—thyroid cancer	5.67e-06	8.94e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	5.66e-06	8.92e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—AKT1—thyroid cancer	5.54e-06	8.74e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—thyroid cancer	5.51e-06	8.68e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—thyroid cancer	5.48e-06	8.64e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	5.46e-06	8.6e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—KRAS—thyroid cancer	5.44e-06	8.58e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—AKT1—thyroid cancer	5.41e-06	8.53e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—AKT1—thyroid cancer	5.38e-06	8.49e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—KRAS—thyroid cancer	5.35e-06	8.44e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—KRAS—thyroid cancer	5.34e-06	8.42e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—AKT1—thyroid cancer	5.34e-06	8.41e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—thyroid cancer	5.33e-06	8.4e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—HRAS—thyroid cancer	5.27e-06	8.3e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTEN—thyroid cancer	5.25e-06	8.27e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—thyroid cancer	5.25e-06	8.27e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	5.24e-06	8.26e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—HRAS—thyroid cancer	5.24e-06	8.26e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—HRAS—thyroid cancer	5.1e-06	8.04e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	5.02e-06	7.91e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTEN—thyroid cancer	4.94e-06	7.79e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	4.87e-06	7.68e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—thyroid cancer	4.84e-06	7.62e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	4.82e-06	7.6e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—thyroid cancer	4.76e-06	7.5e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—thyroid cancer	4.75e-06	7.49e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARG—thyroid cancer	4.71e-06	7.43e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—thyroid cancer	4.66e-06	7.34e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—AKT1—thyroid cancer	4.65e-06	7.33e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AKT1—thyroid cancer	4.63e-06	7.29e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HRAS—thyroid cancer	4.63e-06	7.29e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—HRAS—thyroid cancer	4.55e-06	7.17e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HRAS—thyroid cancer	4.54e-06	7.16e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AKT1—thyroid cancer	4.5e-06	7.09e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	4.46e-06	7.02e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	4.43e-06	6.98e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—AKT1—thyroid cancer	4.37e-06	6.89e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—thyroid cancer	4.33e-06	6.82e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	4.14e-06	6.53e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AKT1—thyroid cancer	4.08e-06	6.44e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AKT1—thyroid cancer	4.02e-06	6.33e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AKT1—thyroid cancer	4.01e-06	6.32e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—AKT1—thyroid cancer	4.01e-06	6.32e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	3.93e-06	6.2e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.71e-06	5.84e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	3.66e-06	5.76e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTEN—thyroid cancer	3.23e-06	5.09e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AKT1—thyroid cancer	3.02e-06	4.77e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AKT1—thyroid cancer	2.85e-06	4.49e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AKT1—thyroid cancer	1.86e-06	2.94e-05	CbGpPWpGaD
